Stock AMBRX INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Ambrx Inc Stock

Equities

US02337M1018

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Ambrx Inc
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Press releases Ambrx Inc

Ambrx : Innovative Antibody Drug Conjugate (ADC) US IND Active PU
Ambrx : closes $45M round of financing PU
Ambrx : Announces New Chief Medical Officer PU
Ambrx : Names Dr. Tiecheng Qiao as CEO, Dr. Feng Tian as CSO PU
Ambrx : Chinese Consortium Enters into Agreement to Acquire Ambrx PU
More press releases

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+2.93% 108B
ARGENX SE Stock argenx SE
-0.61% 23.46B
BIONTECH SE Stock BioNTech SE
-14.60% 21.72B
GENMAB A/S Stock Genmab A/S
-7.05% 18.64B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.55% 17.45B
BEIGENE, LTD. Stock BeiGene, Ltd.
-8.83% 17.19B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.51% 13.99B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.49% 12.53B
VIKING THERAPEUTICS, INC. Stock Viking Therapeutics, Inc.
+329.39% 8.81B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW